Literature DB >> 14510948

Veno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemia.

Sara Stoneham1, Lynne Lennard, Pietro Coen, John Lilleyman, Vaskar Saha.   

Abstract

The case records of 99 consecutive children with acute lymphoblastic leukaemia who received either 6-thioguanine (6-TG) or 6-mercaptopurine (6-MP) as maintenance therapy for at least 1 year were reviewed for hepatic veno-occlusive disease (VOD). Overall, 12% of those on 6-TG developed VOD (all boys). Isolated persistent thrombocytopenia appeared to be the earliest indicator of incipient VOD. Multivariate analysis identified male sex and 6-TG as risk factors. In all cases, VOD was mild and reversible on withdrawing 6-TG or replacing it with 6-MP. The data implicate a sex-linked polymorphic variation in xenobiotic pathways of thiopurine metabolism in the pathogenesis of VOD.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14510948     DOI： 10.1046/j.1365-2141.2003.04578.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  12 in total

1.  Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.

Authors:  G Vernier-Massouille; J Cosnes; M Lemann; P Marteau; W Reinisch; D Laharie; G Cadiot; Y Bouhnik; M De Vos; A Boureille; B Duclos; P Seksik; J-Y Mary; J-F Colombel
Journal:  Gut       Date:  2007-05-15       Impact factor: 23.059

2.  Ancestry and pharmacogenetics of antileukemic drug toxicity.

Authors:  Shinji Kishi; Cheng Cheng; Deborah French; Deqing Pei; Soma Das; Edwin H Cook; Nobuko Hijiya; Carmelo Rizzari; Gary L Rosner; Tony Frudakis; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

3.  Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.

Authors:  Linda C Stork; Yousif Matloub; Emmett Broxson; Mei La; Rochelle Yanofsky; Harland Sather; Ray Hutchinson; Nyla A Heerema; April D Sorrell; Margaret Masterson; Archie Bleyer; Paul S Gaynon
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

4.  A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.

Authors:  Alexander Teml; Matthias Schwab; Daan W Hommes; Sven Almer; Milan Lukas; Thomas Feichtenschlager; Timothy Florin; Julia Seiderer; Wolfgang Petritsch; Bernd Bokemeyer; Wolfgang Kreisel; Klaus R Herrlinger; Peter Knoflach; Bruno Bonaz; Thomas Klugmann; Hans Herfarth; Nikolaus Pedarnig; Walter Reinisch
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

5.  TPMT and MTHFR genotype is not associated with altered risk of thioguanine-related sinusoidal obstruction syndrome in pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Lisa Wray; Marijana Vujkovic; Thomas McWilliams; Shannon Cannon; Meenakshi Devidas; Linda Stork; Richard Aplenc
Journal:  Pediatr Blood Cancer       Date:  2014-04-16       Impact factor: 3.167

6.  Dactinomycin-induced Hepatic Sinusoidal Obstruction Syndrome Responding to Treatment with N-acetylcysteine.

Authors:  Anselm Chi-Wai Lee; Peter Yu-Tang Goh
Journal:  J Cancer       Date:  2011-10-25       Impact factor: 4.207

7.  Chemotherapy induced liver abnormalities: an imaging perspective.

Authors:  Ankush Sharma; Roozbeh Houshyar; Priya Bhosale; Joon-Il Choi; Rajesh Gulati; Chandana Lall
Journal:  Clin Mol Hepatol       Date:  2014-09

8.  Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review.

Authors:  Linea Natalie Toksvang; Magnus Strøh Schmidt; Sofie Arup; Rikke Hebo Larsen; Thomas Leth Frandsen; Kjeld Schmiegelow; Cecilie Utke Rank
Journal:  PLoS One       Date:  2019-05-24       Impact factor: 3.240

9.  Two Cases of Veno-occlusive Disease/Sinusoidal Obstruction Syndrome After Thioguanine Treatment for Acute Lymphoblastic Leukemia.

Authors:  Bernd Gruhn; Grit Brodt; Hans-Joachim Mentzel; Jana Ernst
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

10.  Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective.

Authors:  Danny Ngo; Jemianne Bautista Jia; Christopher S Green; Anjalie T Gulati; Chandana Lall
Journal:  Insights Imaging       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.